Drug data last refreshed 4h ago · AI intelligence enriched 4d ago
SOLUPREP S is a topical antiseptic solution combining chlorhexidine gluconate and isopropyl alcohol for skin antisepsis and disinfection. It is used primarily as a pre-operative skin preparation and for general antiseptic purposes in clinical settings. The dual-agent formulation provides broad-spectrum antimicrobial activity through chlorhexidine's sustained action and isopropyl alcohol's rapid microbicidal effect.
Product is at peak commercial maturity with moderate competitive pressure (30%), positioning the brand team to focus on market defense and operational efficiency rather than growth initiatives.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Roles on SOLUPREP S are primarily commercial and operational in nature, centered on defending market share against generics and managing formulary relationships in hospital settings. Career growth is limited by the product's maturity and impending LOE, making this a stable but not expansion-oriented position.
Worked on SOLUPREP S at Becton Dickinson? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/mo